Welcome to our Institute of Molecular Psychiatry
The major research focus of our Institute is the role of specific molecular, genetic processes in the development of psychiatric diseases.
In particular, as many neurodegenerative diseases are associated with disturbances in energy metabolism, Prof. Rudi Balling is interested in computational models of the citric acid cycle, the major cellular energy production pathway, and its coupling with metabolic and signalling pathways.
Dr. Andras Bilkei-Gorzo 's main research interest is brain ageing and the role of the cannabinoid system in this process.
In his current projects, he plans to elucidate the mechanism of the anti-aging effect of tetrahydrocannabinol - THC - and how the cannabinoid system as a safe keeper controls brain-body interactions during ageing.
News!!!
New Publication by Osteoarthritis Cartilage
Ablation of Hypothalamic Cnr1 Leads to Reduced Meniscal Mineral Volume and Articular Cartilage Damage in Aging Male Mice
https://www.sciencedirect.com/science/article/pii/S1063458425011161?via%3Dihub
New Publication by Experimental Gerontology
Shorter life- and health-span, disturbed insulin-like growth factor signalling in cannabinoid receptor type-1 knockout mice
https://www.sciencedirect.com/science/article/pii/S0531556525001391?via%3Dihub
New Publication by FEBS Journal
Fatty-acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis
https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.17403
Researcher Stories
© Andras Bilkei-Gorzo
Bidirectional effect of long-term Δ9 -tetrahydrocannabinol-treatment on mTOR activity and metabolome
© Michela Palmisano
Local cannabinoid receptor type-1 regulates glial cell activity and insulin-like growth factor-1 receptor signaling in the mediobasal hypothalamus
© Alessandra Gargano